Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists

Table 2 Frequencies of LA abnormalities in the study population

	VKA, n = 138 (45 %)	Dabigatran, n = 68 (22 %)	Rivaroxaban, n = 100 (33 %)	p value for difference between VKA and Dabigatran	p value for difference between VKA and Rivaroxaban	pvalue for difference between dabigatran and rivaroxaban
LA/LAA thrombus	5 (4 %)	0 (0 %)	2 (2 %)	0.173	0.515	0.702
Dense SEC	2 (1 %)	1 (1 %)	2 (2 %)	1	1	1
LAAV <20 cm/s	5 (4 %)	1 (1 %)	1 (1 %)	0.666	1	0.405
LA abnormality	12 (9 %)	2 (3 %)	5 (5 %)	0.15	0.702	0.318

LA left atrium, LAA left atrial appendage, LAAV left atrial appendage velocity, SEC spontaneous echo contrast, VKA vitamin K antagonists

ISSN: 2047-783X